Inverse agonist activities of β-adrenoceptor antagonists in rat myocardium

被引:42
作者
Varma, DR
Shen, H
Deng, XF
Peri, KG
Chemtob, S
Mulay, S
机构
[1] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada
[3] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada
[4] Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada
关键词
ICI-118,551; beta(1)AR antagonists; nonselective beta AR antagonists; beta AR proteins; inotropic responses; isoprenaline; salbutamol;
D O I
10.1038/sj.bjp.0702616
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Negative inotropic effects of several beta-adrenoceptor (beta AR) antagonists on electrically-stimulated right atria, left atria, right ventricles and left ventricular papillary muscles from reserpine-treated rats were used as a measure of their inverse agonist activities. 2 beta(1)AR antagonists acebutolol, atenolol and metoprolol, beta(2)AR antagonist ICI-181,551 and nonselective beta AR antagonists alprenolol, nadolol, propranolol and timolol produced negative inotropic effects, which were most marked on the right atria. 3 The nonselective beta AR antagonist pindolol did not exhibit inverse agonist activity but inhibited the negative inotropic activities of ICI-118,551, atenolol and propranolol. 4 The negative inotropic effects of lidocaine, nifedipine and pentobarbitone were similar on all the four myocardial preparations. 5 The positive inotropic efficacy of salbutamol on right and left atria but not on right ventricles and papillary muscles was comparable to that of isoprenaline. The antagonist activity of ICI-118,551 against isoprenaline was greater on right atria than on other cardiac regions. 6 beta(1)AR proteins were expressed in all regions of the heart but of beta(2)AR were primarily localized in the right atrium. 7 It is concluded that beta(2)AR play a greater role in right atria than in other cardiac regions and almost all beta AR antagonists behave as inverse agonists.
引用
收藏
页码:895 / 902
页数:8
相关论文
共 33 条
[1]  
BARKER EL, 1994, J BIOL CHEM, V269, P11687
[2]  
BESSE JC, 1976, J PHARMACOL EXP THER, V197, P66
[3]   THE PHARMACOLOGY OF A BETA-2-SELECTIVE ADRENOCEPTOR ANTAGONIST (ICI-118,551) [J].
BILSKI, AJ ;
HALLIDAY, SE ;
FITZ GERALD, JD ;
WALE, JL .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) :430-437
[4]   PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR [J].
BOND, RA ;
LEFF, P ;
JOHNSON, TD ;
MILANO, CA ;
ROCKMAN, HA ;
MCMINN, TR ;
APPARSUNDARAM, S ;
HYEK, MF ;
KENAKIN, TP ;
ALLEN, LF ;
LEFKOWITZ, RJ .
NATURE, 1995, 374 (6519) :272-276
[5]   INTERACTION OF CONVULSIVE LIGANDS WITH BENZODIAZEPINE RECEPTORS [J].
BRAESTRUP, C ;
SCHMIECHEN, R ;
NEEF, G ;
NIELSEN, M ;
PETERSEN, EN .
SCIENCE, 1982, 216 (4551) :1241-1243
[6]   COEXISTENCE OF BETA-1-ADRENOCEPTORS AND BETA-2-ADRENOCEPTORS IN THE RABBIT HEART - QUANTITATIVE-ANALYSIS OF THE REGIONAL DISTRIBUTION BY (-)-H-3-DIHYDROALPRENOLOL BINDING [J].
BRODDE, OE ;
LEIFERT, FJ ;
KREHL, HJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (01) :34-43
[7]  
BRODDE OE, 1991, PHARMACOL REV, V43, P203
[8]  
BRYAN LJ, 1981, J PHARMACOL EXP THER, V216, P395
[9]  
Chidiac P, 1996, MOL PHARMACOL, V50, P662
[10]  
CHIDIAC P, 1994, MOL PHARMACOL, V45, P490